Novel salt of 1, 3, 5-triazine-2, 4, 6-triamine derivative

Details for Australian Patent Application No. 2009201337 (hide)

Owner Astellas Pharma Inc

Inventors Kawano, Noriyuki; Kimura, Takenori; Ohmori, Junya; Mizoguchi, Ryo; Hamada, Noritaka; Miyamoto, Satoshi; Kasai, Makoto

Agent Davies Collison Cave

Pub. Number AU-A-2009201337

Filing date 6 April 2009

Wipo publication date 21 October 2010

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 April 2009 Complete Application Filed

21 October 2010 Application Open to Public Inspection

  Published as AU-A-2009201337

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201338-Novel pharmaceutical composition for treatment of schizophrenia

2009201336-Inclined baby support